skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Hyperbaric oxygen ameliorates worsening signs and symptoms of post-traumatic stress disorder

Case report

(2051) Views  (342) Full article downloads

Authors: Benjamin Eovaldi, Claude Zanetti

Published Date December 2010 Volume 2010:6(1) Pages 785 - 789
DOI: http://dx.doi.org/10.2147/NDT.S16071

Benjamin Eovaldi1, Claude Zanetti2
1Department of Medicine, Chicago College of Osteopathic Medicine, Chicago, IL, USA; 2Department of Hyperbaric Medicine, Swedish Covent Hospital, Chicago, IL, USA

Abstract: Hyperbaric oxygen therapy at 2.4 atmospheric pressure absolutes for 90 minutes per day ameliorated the signs and symptoms of agitation, confusion, and emotional distress in a 27-year-old male seven days following a traumatic accident. Hyperbaric oxygen was used to treat the patient's crush injury and underlying nondisplaced pelvic fractures which were sustained in a bicycle versus automobile traffic accident. Its effect on the patient's neuropsychiatric symptoms was surprising and obvious immediately following the initial hyperbaric oxygen treatment. Complete cognitive and psychiatric recovery was achieved by the seventh and final hyperbaric oxygen treatment. We propose that hyperbaric oxygen was effective in improving the patient's neuropsychiatric symptoms by reducing cerebral oxidative stress, inflammation, vasogenic edema, and hippocampal neuronal apoptosis. Further investigation into the use of hyperbaric oxygen as a novel therapy for the secondary prevention of post-traumatic stress disorder that often accompanies postconcussive syndrome may be warranted. We acknowledge that hyperbaric oxygen therapy has been shown to have a strong placebo effect on neurologic and psychiatric diseases.

Keywords: hyperbaric oxygen, post-traumatic stress disorder, neuropsychiatric, acute stress disorder






Readers of this article also read:

Novel research translates to clinical cases of schizophrenic and cocaine psychosis
Role of endocannabinoids in regulating drug dependence
Excited delirium: Consideration of selected medical and psychiatric issues
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Body dysmorphic disorder: A complex and polymorphic affection
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
Neurocognitive impairment after off-pump and on-pump coronary artery bypass graft surgery – an Iranian experience
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography